Advertisements

Shi, Michael

Novartis International AG, United States

2024 Rank: 128,649

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Biochemistry & Molecular Biology

Rank in SubField 1: 4,884 out of 334,837 Researchers

Data For The Year: 2024
Metrics Self-Citations Excluded All
Rank Based on Composite Score128,649144,792
Total Cites12,59714,081
H-index3333
Hm-index88
Number of Single Authored Papers55
Total Cites to Single Authored Papers295295
Number of Single+First Authored Papers1818
Total Cites to Single+First Authored Papers1,0231,106
Number of Single+First+Last Authored Papers2222
Total Cites to Single+First+Last Authored Papers1,1141,200
Composite Score33
Number of Distinct Citing Papers11,19612,424
Ratio of Total Citations to Distinct Citing Papers 1.13 1.13
Self-Citation Percentage
10.54%
Found an error in your data? Contact us with your profile link. Contact Us →

Shi, Michael

Novartis International AG, United States

2023 Rank: 121,200

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Biochemistry & Molecular Biology

Rank in SubField 1: 4,692 out of 312,644 Researchers

Data For The Year: 2023
Metrics Self-Citations Excluded All
Rank Based on Composite Score121,200136,512
Total Cites12,23413,714
H-index3333
Hm-index88
Number of Single Authored Papers55
Total Cites to Single Authored Papers293293
Number of Single+First Authored Papers1818
Total Cites to Single+First Authored Papers1,0101,093
Number of Single+First+Last Authored Papers2222
Total Cites to Single+First+Last Authored Papers1,0931,179
Composite Score33
Number of Distinct Citing Papers10,85612,078
Ratio of Total Citations to Distinct Citing Papers 1.13 1.14
Self-Citation Percentage
10.79%
Found an error in your data? Contact us with your profile link. Contact Us →

Shi, Michael

Novartis International AG, United States

2022 Rank: 110,187

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Biochemistry & Molecular Biology

Rank in SubField 1: 4,311 out of 293,195 Researchers

Data For The Year: 2022
Metrics Self-Citations Excluded All
Rank Based on Composite Score110,187124,598
Total Cites11,76313,224
H-index3333
Hm-index88
Number of Single Authored Papers55
Total Cites to Single Authored Papers289289
Number of Single+First Authored Papers1818
Total Cites to Single+First Authored Papers1,0021,085
Number of Single+First+Last Authored Papers2222
Total Cites to Single+First+Last Authored Papers1,0751,161
Composite Score33
Number of Distinct Citing Papers10,41311,620
Ratio of Total Citations to Distinct Citing Papers 1.13 1.14
Self-Citation Percentage
11.05%
Found an error in your data? Contact us with your profile link. Contact Us →

Shi, Michael

Novartis International AG, United States

2021 Rank: 104,997

Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:

Clinical Medicine

SubField 1:

Oncology & Carcinogenesis

SubField 2:

Biochemistry & Molecular Biology

Rank in SubField 1: 4,135 out of 271,773 Researchers

Data For The Year: 2021
Metrics Self-Citations Excluded All
Rank Based on Composite Score104,997118,827
Total Cites11,28812,702
H-index3333
Hm-index88
Number of Single Authored Papers55
Total Cites to Single Authored Papers287287
Number of Single+First Authored Papers1818
Total Cites to Single+First Authored Papers9931,076
Number of Single+First+Last Authored Papers2222
Total Cites to Single+First+Last Authored Papers1,0591,145
Composite Score33
Number of Distinct Citing Papers10,00211,172
Ratio of Total Citations to Distinct Citing Papers 1.13 1.14
Self-Citation Percentage
11.13%
Found an error in your data? Contact us with your profile link. Contact Us →
Advertisements

Partner with TOPSCINET

Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.

Advertisements